Overview
The kick-off meeting for the Global Antibiotic Resistance Partnership (GARP)–Kenya took place on March 15, 2024. The discussion highlighted Kenya’s growing challenge of antimicrobial resistance (AMR), driven in part by increasing antibiotic consumption. Following this meeting, the GARP–Kenya technical working group, a collaboration between the One Health Trust and Kenya Medical Research Institute (KEMRI), has been working to explore the role of vaccines in reducing unnecessary antibiotic use and to develop evidence-based policy recommendations for strengthening Kenya’s AMR response.
On this page, find the team’s policy brief, additional resources, and media on how vaccines can be leveraged to reduce the burden of AMR in Kenya.
GARP-Kenya Policy Brief
The Value of Vaccines in Mitigating Antimicrobial Resistance in Kenya
New report urges Kenya to unleash the power of vaccines in fight against drug-resistant infections
Vaccine Rising as Key Weapon Against Rising Drug-Resistance in Kenya
Kenya Launches Report Highlighting Vaccines as Key Weapon Against Drug Resistance
Kenya Urged to Scale Up Vaccine Use in Fight Against Drug-Resistant Infections
GARP-Kenya Inforgraphics
